NAD+ loss, a new player in AhR biology: Prevention of thymus atrophy and hepatosteatosis by NAD+ repletion

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Diani Moore, Silvia ^a   Shoots, Jenny ^a   Singh, Rubi ^a   Zuk, Joshua B ^a   Rifkind, Arleen B ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; DIOXIN; NICOTINAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; SIRTUIN;

ANIMAL; ATROPHY; CELL LINE; CHICK EMBRYO; DRUG EFFECT; FATTY LIVER; GENETICS; METABOLISM; PATHOLOGY; THYMUS;

ANIMALS; ATROPHY; CELL LINE; CHICK EMBRYO; DIOXINS; FATTY LIVER; NAD; NIACINAMIDE; POLY(ADP-RIBOSE) POLYMERASE INHIBITORS; POLY(ADP-RIBOSE) POLYMERASES; RECEPTORS, ARYL HYDROCARBON; SIRTUINS; THYMUS GLAND;

EID: 85019612811     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-02332-9     Document Type: Article

References (47)

1. Okey, A. B., Riddick, D. S. & Harper, P. A. The Ah receptor: mediator of the toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and related compounds. Toxicol. Lett. 70, 1-22 (1994).
2. Bunger, M. K. et al. Resistance to 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity and abnormal liver development in mice carrying a mutation in the nuclear localization sequence of the aryl hydrocarbon receptor. J Biol Chem 278, 17767-17774 (2003).
3. Poland, A. & Knutson, J. C. 2,3,7,8-tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Annu. Rev. Pharmacol. Toxicol. 22, 517-554 (1982).
4. Okey, A. B. An aryl hydrocarbon receptor odyssey to the shores of toxicology: the Deichmann Lecture, International Congress of Toxicology-XI. Toxicol. Sci. 98, 5-38 (2007).
5. Hahn, M. E., Allan, L. L. & Sherr, D. H. Regulation of constitutive and inducible AHR signaling: complex interactions involving the AHR repressor. Biochem. Pharmacol. 77, 485-497 (2009).
6. Boverhof, D. R. et al. Comparative toxicogenomic analysis of the hepatotoxic effects of TCDD in Sprague Dawley rats and C57BL/6 mice. Toxicol. Sci 94, 398-416 (2006).
7. Diani-Moore, S. et al. Identification of the aryl hydrocarbon receptor target gene TiPARP as a mediator of suppression of hepatic gluconeogenesis by 2,3,7,8-tetrachlorodibenzo-p-dioxin and of nicotinamide as a corrective agent for this effect. J. Biol. Chem. 285, 38801-38810 (2010).
8. Houtkooper, R. H. & Auwerx, J. Exploring the therapeutic space around NAD+. J. Cell Biol. 199, 205-209 (2012).
9. Ma, Q., Baldwin, K. T., Renzelli, A. J., McDaniel, A. & Dong, L. TCDD-inducible poly(ADP-ribose) polymerase: a novel response to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Biochem. Biophys. Res. Commun. 289, 499-506 (2001).
10. Boutros, P. C., Bielefeld, K. A., Pohjanvirta, R. & Harper, P. A. Dioxin-dependent and dioxin-independent gene batteries: comparison of liver and kidney in AHR-null mice. Toxicol. Sci 112, 245-256 (2009).
11. Tijet, N. et al. Aryl hydrocarbon receptor regulates distinct dioxin-dependent and dioxin-independent gene batteries. Mol. Pharmacol. 69, 140-153 (2006).
12. Laiosa, M. D. et al. Cell proliferation arrest within intrathymic lymphocyte progenitor cells causes thymic atrophy mediated by the aryl hydrocarbon receptor. J. Immunol. 171, 4582-4591 (2003).
13. Boverhof, D. R. et al. Temporal and dose-dependent hepatic gene expression patterns in mice provide new insights into TCDDmediated hepatotoxicity. Toxicol. Sci. 85, 1048-1063 (2005).
14. Angrish, M. M., Mets, B. D., Jones, A. D. & Zacharewski, T. R. Dietary fat is a lipid source in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-elicited hepatic steatosis in C57BL/6 mice. Toxicol. Sci 128, 377-386 (2012).
15. Lee, J. H. et al. A novel role for the dioxin receptor in fatty acid metabolism and hepatic steatosis. Gastroenterology 139, 653-663 (2010).
16. MacPherson, L. et al. 2,3,7,8-Tetrachlorodibenzo-p-dioxin poly(ADP-ribose) polymerase (TiPARP, ARTD14) is a mono-ADPribosyltransferase and repressor of aryl hydrocarbon receptor transactivation. Nucleic Acids Res 41, 1604-1621 (2013).
17. Revollo, J. R., Grimm, A. A. & Imai, S. The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells. J. Biol. Chem. 279, 50754-50763 (2004).
18. Bieganowski, P. & Brenner, C. Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a Preiss-Handler independent route to NAD+ in fungi and humans. Cell 117, 495-502 (2004).
19. Canto, C. et al. The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat dietinduced obesity. Cell Metab. 15, 838-847 (2012).
20. Bai, P. et al. PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. Cell Metab. 13, 461-468 (2011).
21. Sharma, A., Singh, K. & Almasan, A. Histone H2AX phosphorylation: a marker for DNA damage. Methods Mol. Biol 920, 613-626 (2012).
22. Abdelkarim, G. E. et al. Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke. Int. J. Mol. Med. 7, 255-260 (2001).
23. Yang, T. & Sauve, A. A. NAD Metabolism and Sirtuins: Metabolic Regulation of Protein Deacetylation in Stress and Toxicity. AAPS J. 8, E632-643 (2006).
24. Hottiger, M. O. Nuclear ADP-Ribosylation and Its Role in Chromatin Plasticity, Cell Differentiation, and Epigenetics. Annu. Rev. Biochem. 84, 227-263 (2015).
25. Mostoslavsky, R. et al. Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell 124, 315-329 (2006).
26. Kim, H. S. et al. Hepatic-specific disruption of SIRT6 in mice results in fatty liver formation due to enhanced glycolysis and triglyceride synthesis. Cell Metab. 12, 224-236 (2010).
27. Michishita, E. et al. Cell cycle-dependent deacetylation of telomeric histone H3 lysine K56 by human SIRT6. Cell Cycle 8, 2664-2666 (2009).
28. Virag, L., Robaszkiewicz, A., Rodriguez-Vargas, J. M. & Oliver, F. J. Poly(ADP-ribose) signaling in cell death. Molecular aspects of medicine 34, 1153-1167 (2013).
29. Michishita, E. et al. SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin. Nature 452, 492-496 (2008).
30. Mukhopadhyay, P. PARP inhibition protects against alcoholic and nonalcoholic steatohepatitis. Journal of hepatology (2016).
31. Gariani, K. et al. Eliciting the mitochondrial unfolded protein response by nicotinamide adenine dinucleotide repletion reverses fatty liver disease in mice. Hepatology 63, 1190-1204 (2016).
32. Ray, K. Steatohepatitis: PARP inhibition protective against alcoholic steatohepatitis and NASH. Nature reviews. Gastroenterology & hepatology 14, 3 (2017).
33. Bai, P. Biology of Poly(ADP-Ribose) Polymerases: The Factotums of Cell Maintenance. Mol Cell 58, 947-958 (2015).
34. Yang, S. J. et al. Activation of peroxisome proliferator-activated receptor gamma by rosiglitazone increases sirt6 expression and ameliorates hepatic steatosis in rats. PLoS One 6, e17057 (2011).
35. Kawahara, T. L. et al. SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span. Cell 136, 62-74 (2009).
36. He, J. et al. Activation of the aryl hydrocarbon receptor sensitizes mice to nonalcoholic steatohepatitis by deactivating mitochondrial sirtuin deacetylase Sirt3. Mol Cell Biol 33, 2047-2055 (2013).
37. Hakme, A., Huber, A., Dolle, P. & Schreiber, V. The macroPARP genes Parp-9 and Parp-14 are developmentally and differentially regulated in mouse tissues. Dev. Dyn. 237, 209-215 (2008).
38. Rouleau, M., El-Alfy, M., Levesque, M. H. & Poirier, G. G. Assessment of PARP-3 distribution in tissues of cynomolgous monkeys. J. Histochem. Cytochem. 57, 675-685 (2009).
39. De Jong, W. H., Kroese, E. D., Vos, J. G. & Van Loveren, H. Detection of immunotoxicity of benzo[a]pyrene in a subacute toxicity study after oral exposure in rats. Toxicol. Sci 50, 214-220 (1999).
40. Smialowicz, R. J. et al. Evaluation of the immunotoxicity of low level PCB exposure in the rat. Toxicology 56, 197-211 (1989).
41. Vanscheeuwijck, P. M. et al. Evaluation of the potential effects of ingredients added to cigarettes. Part 4: subchronic inhalation toxicity. Food Chem. Toxicol 40, 113-131 (2002).
42. Nohara, K. et al. Arsenite-induced thymus atrophy is mediated by cell cycle arrest: a characteristic downregulation of E2F-related genes revealed by a microarray approach. Toxicol. Sci 101, 226-238 (2008).
43. Bai, P. et al. PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation. Cell Metab 13, 461-468 (2011).
44. Taub, D. D. & Longo, D. L. Insights into thymic aging and regeneration. Immunol. Rev. 205, 72-93 (2005).
45. Massudi, H. et al. Age-Associated Changes In Oxidative Stress and NAD(+) Metabolism In Human Tissue. PLoS One 7, e42357.
46. Rifkind, A. B., Kanetoshi, A., Orlinick, J., Capdevila, J. H. & Lee, C. Purification and biochemical characterization of two major cytochrome P-450 isoforms induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in chick embryo liver. J Biol Chem 269, 3387-3396 (1994).
47. Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 25, 402-408 (2001).